KLK3 and posterior cortical atrophy: Local guidelines [13] defined tumors of the low-, intermediate-, and high-risk groups as clinically significant, while only cases in the very-low-risk category (PSA < 10 ng/mL, GS6 PCa in <50% of biopsies and in ≤2 cores involved) were seen as clinically insignificant, and AS was recommended.